Summary: Cheung and colleagues identify PIK3R1 and PIK3R2, the genes encoding the α and β isoforms of the phosphatidylinositol 3-kinase (PI3K) p85 regulatory subunit, as additional mutation targets in endometrial cancer, and describe a novel mechanism leading to PTEN loss. Cancer Discovery; 1(2); 106–7. ©2011 AACR. IN THE SPOTLIGHT cancer model ( 9). This notion, supported by an initial analy-sis of the correlation between EC genetic alterations and cell line response to mTOR, PI3K, and mitogen-activated protein kinase inhibitors, will now open the way to a more rational combination of targeted therapies in advanced EC patients. Most importantly, this study also reveals a relatively high rate of mutations in the genes encoding the α and β...
Signals from the tumor suppressors PTEN and LKB1 converge on mTOR to negatively regulate its functio...
Molecular and genetic investigations in endometrial carcinogenesis may have prognostic and therapeut...
Purpose: PIK3CA and PTEN mutations are prevalent in colorectal cancer and potential markers of respo...
We demonstrate that phosphatidylinositol 3-kinase (PI3K) pathway aberrations occur in.80% of endomet...
The conference is also named as 'Innovations in Cancer Prevention and Research Conference'Introducti...
BACKGROUND: The phosphoinositide-3-kinase (PI3K) pathway is the most commonly activated pathway in c...
Summary: Protein kinase C (PKC) isozymes are commonly recognized as oncoproteins based on their acti...
Mutations of the phosphoinositide-3-kinase (PI3K) catalytic subunit alpha gene (PIK3CA) are frequent...
10.3389/fonc.2022.1088962 Abstract: Endometrial cancer (EC) is the most common gynecologic cancer i...
A growing number of mutations in PIK3R1, the gene that encodes for the p85α regulatory subunit of PI...
Dysregulation of the PI3K/PTEN pathway is a frequent event in cancer, and PIK3CA and PTEN are the mo...
Although 75% of endometrial cancers are treated at an early stage, 15% to 20% of these recur. We per...
Although 75% of endometrial cancers are treated at an early stage, 15% to 20% of these recur. We per...
The aim of this study was to determine the clinicopathological impact of PIK3CA mutations and phosph...
To investigate the clinicopathologic and prognostic implications of phosphoinositide 3 kinase (PI3K)...
Signals from the tumor suppressors PTEN and LKB1 converge on mTOR to negatively regulate its functio...
Molecular and genetic investigations in endometrial carcinogenesis may have prognostic and therapeut...
Purpose: PIK3CA and PTEN mutations are prevalent in colorectal cancer and potential markers of respo...
We demonstrate that phosphatidylinositol 3-kinase (PI3K) pathway aberrations occur in.80% of endomet...
The conference is also named as 'Innovations in Cancer Prevention and Research Conference'Introducti...
BACKGROUND: The phosphoinositide-3-kinase (PI3K) pathway is the most commonly activated pathway in c...
Summary: Protein kinase C (PKC) isozymes are commonly recognized as oncoproteins based on their acti...
Mutations of the phosphoinositide-3-kinase (PI3K) catalytic subunit alpha gene (PIK3CA) are frequent...
10.3389/fonc.2022.1088962 Abstract: Endometrial cancer (EC) is the most common gynecologic cancer i...
A growing number of mutations in PIK3R1, the gene that encodes for the p85α regulatory subunit of PI...
Dysregulation of the PI3K/PTEN pathway is a frequent event in cancer, and PIK3CA and PTEN are the mo...
Although 75% of endometrial cancers are treated at an early stage, 15% to 20% of these recur. We per...
Although 75% of endometrial cancers are treated at an early stage, 15% to 20% of these recur. We per...
The aim of this study was to determine the clinicopathological impact of PIK3CA mutations and phosph...
To investigate the clinicopathologic and prognostic implications of phosphoinositide 3 kinase (PI3K)...
Signals from the tumor suppressors PTEN and LKB1 converge on mTOR to negatively regulate its functio...
Molecular and genetic investigations in endometrial carcinogenesis may have prognostic and therapeut...
Purpose: PIK3CA and PTEN mutations are prevalent in colorectal cancer and potential markers of respo...